Michael Raab Ardelyx, Inc. (ARDX) insider trading activity

Michael Raab is President & CEO of ARDELYX, INC.. Currently has a direct ownership of 1.55 Million shares of ARDX, which is worth approximately $6.13 Million. The most recent transaction as insider was on May 20, 2025, when has been sold 46,817 shares (Common Stock) at a price of $4.08 per share, resulting in proceeds of $191,013. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.55M

5.33% 3M change

21.86% 12M change

Total Value Held $6.13 Million

MICHAEL RAAB Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2025	SELL Open market or private sale	$191,013 $4.08 p/Share	46,817 Reduced 2.94%	1,547,937 Common Stock
May 02 2025	SELL Open market or private sale	$177,080 $4.25 p/Share	41,666 Reduced 2.55%	1,594,754 Common Stock
May 02 2025	BUY Exercise of conversion of derivative security	$20,624 $0.99 p/Share	20,833 Added 1.26%	1,636,420 Common Stock
Apr 04 2025	SELL Open market or private sale	$191,246 $4.59 p/Share	41,666 Reduced 2.51%	1,615,587 Common Stock
Apr 04 2025	BUY Exercise of conversion of derivative security	$20,624 $0.99 p/Share	20,833 Added 1.24%	1,657,253 Common Stock
Mar 07 2025	SELL Open market or private sale	$223,340 $5.36 p/Share	41,668 Reduced 2.48%	1,635,138 Common Stock
Mar 07 2025	BUY Exercise of conversion of derivative security	$20,625 $0.99 p/Share	20,834 Added 1.23%	1,676,806 Common Stock
Feb 25 2025	BUY Grant, award, or other acquisition	-	570,217 Added 25.61%	1,655,972 Common Stock
Feb 20 2025	SELL Open market or private sale	$129,057 $5.62 p/Share	22,964 Reduced 2.07%	1,085,755 Common Stock
Jan 31 2025	SELL Open market or private sale	$223,329 $5.36 p/Share	41,666 Reduced 3.62%	1,108,719 Common Stock
Jan 31 2025	BUY Exercise of conversion of derivative security	$20,624 $0.99 p/Share	20,833 Added 1.78%	1,150,385 Common Stock
Jan 07 2025	SELL Open market or private sale	$221,246 $5.31 p/Share	41,666 Reduced 3.56%	1,129,552 Common Stock
Jan 07 2025	BUY Exercise of conversion of derivative security	$20,624 $0.99 p/Share	20,833 Added 1.75%	1,171,218 Common Stock
Dec 10 2024	SELL Open market or private sale	$131,500 $5.26 p/Share	25,000 Reduced 2.13%	1,150,385 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	$24,750 $0.99 p/Share	25,000 Added 2.08%	1,175,385 Common Stock
Nov 25 2024	SELL Open market or private sale	$134,500 $5.38 p/Share	25,000 Reduced 2.13%	1,150,385 Common Stock
Nov 20 2024	SELL Open market or private sale	$153,184 $4.79 p/Share	31,980 Reduced 2.65%	1,175,385 Common Stock
Nov 11 2024	SELL Open market or private sale	$13,440 $4.9 p/Share	2,743 Reduced 0.23%	1,207,365 Common Stock
Oct 28 2024	SELL Open market or private sale	$147,750 $5.91 p/Share	25,000 Reduced 2.02%	1,210,108 Common Stock
Oct 28 2024	BUY Exercise of conversion of derivative security	$24,750 $0.99 p/Share	25,000 Added 1.98%	1,235,108 Common Stock
Oct 11 2024	SELL Open market or private sale	$45,075 $6.01 p/Share	7,500 Reduced 0.62%	1,210,108 Common Stock
Sep 26 2024	SELL Open market or private sale	$18,210 $6.07 p/Share	3,000 Reduced 0.25%	1,217,608 Common Stock
Sep 11 2024	SELL Open market or private sale	$196,350 $5.61 p/Share	35,000 Reduced 2.79%	1,220,608 Common Stock
Sep 11 2024	BUY Exercise of conversion of derivative security	$34,650 $0.99 p/Share	35,000 Added 2.71%	1,255,608 Common Stock
Aug 27 2024	SELL Open market or private sale	$46,650 $6.22 p/Share	7,500 Reduced 0.61%	1,219,509 Common Stock

Also insider at

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

TPST

Tempest Therapeutics, Inc. Healthcare

Michael Raab

President & CEO

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARDX shares.

Notify only if

Value

Insider Trading

Get notified when an Ardelyx, Inc. insider buys or sells ARDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to ARDELYX, INC.

Track Activities on ARDX

Account